Phase Ib/II trial of TG4001 (Tipapkinogene sovacivec), a therapeutic HPV-vaccine, and Avelumab in patients with recurrent/metastatic (R/M) HPV-16+cancers

Le Tourneau, C; Delord, JP; Cassier, P; Loirat, D; Tavernaro, A; Bastien, B; Bendjama, K

ANNALS OF ONCOLOGY, 2019; 30 ():

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索